Clinical Trial

Trial Protocol ID USOR 24004_MCLA-158-CL02 *STAR*

Trial Description

A phase 3 open-label, randomized, controlled study to evaluate the efficacy and safety of petosemtamab compared with investigator’s choice monotherapy treatment in previously treated patients with incurable, metastatic/recurrent head and neck squamous cell carcinoma

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Disease Types

Sponsor

  • Merus N.V.

ClinicalTrials.gov NCT ID

  • NCT06496178